Cyclosporin a inhibits Epstein-Barr virus induced gamma-interferon production in vitro
Andersson, J.; Andersson, U.; Britton, S.; DeLey, M.
Scandinavian Journal of Urology and Nephrology. Supplementum 92: 57-58
1985
ISSN/ISBN: 0300-8886 PMID: 3008318 Document Number: 243909
Document emailed within 1 workday
Related Documents
Fujisaki, T.; Nagafuchi, S.; Okamura, T. 1993: Gamma-interferon for severe chronic active Epstein-Barr virus Annals of Internal Medicine 118(6): 474-475Freijd, A.; Rosén, A. 1984: Epstein-Barr virus induced pneumococcal antibody production in man. a comparison of different lymphoid organs Clinical and Experimental Immunology 55(1): 204-210
Tsuchiya, S.; Yokoyama, S.; Yoshie, O.; Ono, Y. 1980: Production of diphtheria antitoxin antibody in Epstein-Barr virus-induced lymphoblastoid cell lines Journal of Immunology 124(4): 1970-1976
Larrat, S.; Morand, P.; Bas, A.; Vigne, S.; Crance, J.-M.; Boyer, V.ér.; Nicod, S.; Grossi, L.; Buisson, M.; Burmeister, W.P.; Seigneurin, J.-M.; Germi, R.ël. 2009: Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene Antiviral Therapy 14(5): 655-662
Hamilton-Dutoit, S.J.; Pallesen, G. 1992: A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas American Journal of Pathology 140(6): 1315-1325
Yang, T.-t.; Wang, Y.; Liu, X.; Li, X.; Pang, Z.-c.; Luo, B. 2009: Genotyping of Epstein-Barr virus in Epstein-Barr virus associated gastric carcinoma Bing du Xue Bao 25(1): 29-34
Popov, М; Lyadova, Т; Volobuyeva, О; Shepileva, N.; Kozlov, А; Sorokina, О 2017: Cytokine Production Peculiarities in different Forms of Epstein-Barr Virus Infection Georgian Medical News 263: 55-59
Dunkel, V.C. 1973: In vitro and in vivo studies with Epstein-Barr virus (EBV). a review Annals of Clinical and Laboratory Science 3(6): 424-428
Pearson, G.; Dewey, F.; Klein, G.; Henle, G.; Henle, W. 1970: Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus Journal of the National Cancer Institute 45(5): 989-995
Bakken, J.S. 1980: Epstein-Barr-virus induced glomerulonephritis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 100(10): 558-560
Pope, J.H.; Moss, D.J. 1978: Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation Iarc Scientific Publications 1978(24 Part 2): 617-622
Grigorian, S.S.; Pritsker, A.D.; Onufrieva, E.K.; Chireshkin, D.G.; Ershov, F.I. 1991: The effect of exogenous interferon on the in vitro production of alpha- and gamma-interferon by the lymphocytes of patients with respiratory papillomatosis Voprosy Virusologii 36(5): 407-409
Schuster, V.; Kreth, H.W. 1991: Epstein-Barr-virus-induced lymphoproliferative diseases Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 139(7): 396-400
Colpaert, S.; Vastraelen, K.; Liu, Z.; Maerten, P.; Shen, C.; Penninckx, F.; Geboes, K.; Rutgeerts, P.; Ceuppens, J.L. 2002: In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease European Cytokine Network 13(4): 431-437
Furman, E.; Edoute, Y. 1997: Liver dysfunction induced by Epstein-Barr virus infectious mononucleosis Harefuah 132(10): 724-725
Lampa, J.; Klareskog, L.; Rönnelid, J. 2002: Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels Journal of Rheumatology 29(1): 21-28
Tanaka, Y.; Sugamura, K.; Hinuma, Y.; Sato, H.; Okochi, K. 1980: Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method Journal of Immunology 125(4): 1426-1431
Bendtzen, K.; Hansen, P.R.; Rieneck, K. 2004: Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis Ugeskrift for Laeger 166(37): 3203-3207
Crawford, D.H.; Thomas, J.A.; Gregory, C.D.; Catovsky, D.; Chaggar, K. 1995: Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40 Leukemia 9(5): 747-753
Edson, C.M.; Cohen, L.K.; Henle, W.; Strominger, J.L. 1983: An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo Journal of Immunology 130(2): 919-924